09:27 AM EST - Satellos Bioscience Inc. : Announced the appointment of Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs. Ms. Paone brings extensive experience leading regulatory strategy from clinical development through approval, including her work on Kalydeco and Orkambi at Vertex Pharmaceuticals. Satellos Bioscience Inc.
shares T.MSCL are trading unchanged at $1.22.
